Related Experiment Video
Updated: Jul 14, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them.
I Dvorchik1, A J Demetris, D A Geller
1Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. dvorchikig@upmc.edu
Current Pharmaceutical Design
|May 17, 2007
Summary
Hepatocellular carcinoma (HCC) survival varies by stage. This review details prognostic models and statistical methods like survival analysis and artificial neural networks to improve HCC treatment outcomes.
Area of Science:
- Hepatology
- Oncology
- Biostatistics
Background:
- Hepatocellular carcinoma (HCC) causes significant global mortality.
- Curative treatments like surgery and transplantation have variable outcomes.
- Accurate prognostic models are crucial for optimizing HCC patient management.
Purpose of the Study:
- To review common prognostic models for Hepatocellular Carcinoma (HCC).
- To discuss the statistical methodologies underpinning these HCC prognostic models.
Main Methods:
- Review of commonly utilized prognostic models in clinical practice.
- Categorization of statistical methodologies into survival analysis, artificial neural networks, analysis of variance, and cluster analysis.
- Discussion of specific techniques like Cox proportional hazard models and back-propagation networks.
Main Results:
- Survival methodologies (e.g., Cox model) assess risk factors for survival and recurrence.
- Artificial neural networks excel at approximating functions for HCC recurrence prediction.
- Analysis of variance and cluster analysis are key tools for microarray data in cancer research.
Conclusions:
- Prognostic models are essential for improving HCC treatment strategies.
- Diverse statistical methods, including survival analysis and neural networks, aid in HCC prognostication.
- Advanced statistical techniques applied to emerging technologies like microarrays hold promise for HCC research.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...